Neurosteer

Neurosteer is a medical technology company founded in 2015, specializing in brain activity interpretation. The company has developed the hdrEEG, a wearable, medical-grade brain monitor that uses a forehead strip to capture brain activity data. This data is transmitted to the cloud for real-time analysis through a web-based dashboard. Neurosteer holds FDA clearance as a Class II medical device and is involved in clinical and drug trials globally. The hdrEEG system offers continuous brain monitoring and supports the early detection of neurological disorders such as Parkinson’s disease, Alzheimer’s disease, and epilepsy. It also aids in optimizing neurostimulation and drug selection, enhancing treatment outcomes. Neurosteer serves medical professionals, researchers, and pharmaceutical companies, providing tools for neurological assessments and clinical trials. The company is led by CEO Nathan Intrator and supported by a team of experts in various fields, ensuring a strong foundation in both technology and clinical application.

• Employees 12
• Founded 2015
• Total Funding $2000000